Androgen deprivation therapy in Turkey typically costs from $1,500 to $2,500 depending on the specific hormone medications, treatment duration, and chosen clinic tier. In the US, similar hormone treatments cost around $12,500 on average. Patients save around 84% compared to US prices. Standard Turkish medical packages usually include oncologist consultations, initial blood panels, and coordination services for international patients.
Bookimed Expert Insight: Choosing a JCI-accredited center like Anadolu Medical Center offers significant value due to its affiliation with Johns Hopkins Medicine. Patients access top-tier specialists like Dr. Ilker Tinay at approximately $2,000 to $2,500 for total treatment cycles. This is an excellent middle ground where you receive US-standard oncological protocols for a fraction of the cost, often including airport-to-clinic transfers.
| Turkey | Austria | Spain | |
| Androgen deprivation therapy | from $1,500 | from $4,500 | from $3,200 |
Day 1
Day 2
Day 3
Day 4
Week 1
Week 2 to 4
Week 5 onwards
Please note that this is a general guide and individual cases may vary.
The doctor is a highly regarded oncologist at the Anadolu Medical Center, specializing in medical oncology and chemotherapy. After obtaining a medical degree from Ankara University in 2005, the doctor completed specialty training in internal medicine at Istanbul University and further specialized in medical oncology at Marmara University by 2017. The doctor has led the medical oncology unit at Haydarpaşa Numune Training and Research Hospital and has participated in numerous international clinical studies. The doctor focuses on a wide range of cancers, including breast, urological, lung, and gastrointestinal cancers, among others.
The doctor is a member of several prestigious oncology societies, including the Turkish Society of Medical Oncology, the European Society of Medical Oncology, and the American Society of Medical Oncology. The doctor has participated in advanced training programs globally, including programs at Oxford University and ESMO.
The doctor is an Urological Oncologist specializing in Minimal Invasive Surgery, Neo-Bladder Reconstruction, and Urological Cancer at Anadolu Medical Center. With a Bachelor Degree from Istanbul University and a Residency in Urology from Marmara University, the doctor has been recognized with several awards, including the Science Encouragement Award for Residency Students in 2008 and the Young Academic Presentation Award in 2012.
The doctor is an Executive Board Member of the Association of Urooncology and Secretary of the Bladder Tumours Research Group. Additionally, the doctor is a member of the International Bladder Cancer Network, European Association of Urology, and the American College of Surgeons.
Dr. Solak specializes in androgen deprivation therapy, treating complex cases at Hisar Hospital Intercontinental.
Assoc. Prof. Abdullah Sakin leads the Medical Oncology Department at Medipol Bahçelievler Hospital, specializing in androgen deprivation therapy.
Primary treatment methods for androgen deprivation therapy in Turkey center on long-acting GnRH agonists like Lupron and Zoladex, often combined with abiraterone for high-risk cases. Turkish urologists frequently utilize continuous protocols exceeding 18 months, integrated with robotic surgery or radiation to maximize long-term remission rates.
Bookimed Expert Insight: Bookimed data shows Turkey’s leading oncologists, such as Prof. Necdet Uskent at Anadolu Medical Center, often extend hormone therapy protocols beyond 18 months. While Western standards sometimes offer shorter courses, this continuous approach in Turkey aims to minimize recurrence for high-risk patients. Because these medications are priced between $1,500 and $2,500, patients can afford longer-duration care that would be cost-prohibitive elsewhere.
Patient Consensus: Patients report rapid PSA drops with 3-month Lupron injections but emphasize the need for regular exercise. Many suggest using affordable local lab services for monthly monitoring to manage fatigue and bone health effectively.
Androgen deprivation therapy commonly causes hot flashes, fatigue, and sexual dysfunction as male hormone levels drop. Patients frequently experience muscle mass loss, weight gain, and mood changes like irritability or depression. Long-term risks include decreased bone density and a higher chance of cardiovascular issues or type-2 diabetes.
Bookimed Expert Insight: While treatment in Turkey costs $1,500 to $2,500—saving up to 84% over US prices—the physiological impact remains identical. Leading centers like Anadolu Medical Center, affiliated with Johns Hopkins, emphasize early intervention. We see the best outcomes when patients start resistance training and vitamin D supplementation the same week they begin injections.
Patient Consensus: Many describe the fatigue as a heavy exhaustion tied to losing 20lbs of muscle in 6 months. They recommend discussing intimacy changes with partners early to manage the emotional weight of near-universal sexual side effects.
Patients receiving androgen deprivation therapy in Turkey typically require follow-up appointments every 3 to 6 months. These visits are essential for monitoring prostate-specific antigen levels and testosterone suppression. Standard schedules involve quarterly check-ups for the first 2 to 3 years before transitioning to annual reviews.
Bookimed Expert Insight: Data from major centers like Anadolu Medical Center shows a trend toward personalized monitoring. While standard guidelines suggest 3-month intervals, surgeons often adjust schedules based on individual PSA velocity. Clinics affiliated with international bodies often prioritize bone health screenings during these visits to mitigate long-term therapy risks.
Patient Consensus: Patients emphasize the importance of 3-month bloodwork to catch early PSA spikes. Many find that tracking side effects like fatigue at home helps make quarterly consultations more productive.
Istanbul, Ankara, and Antalya are the primary hubs for high-quality androgen deprivation therapy in Turkey. Clinics like Anadolu Medical Center and Memorial Sisli utilize Joint Commission International (JCI) standards and European Association of Urology (EAU) protocols to manage advanced prostate cancer through specialized hormonal interventions.
Bookimed Expert Insight: Anadolu Medical Center stands out because it combines JCI safety with specialized IASIOS certification for interventional oncology. This dual credentialing is rare. It ensures that medical hormone therapy is integrated with advanced surgical and radiological standards for better staging.
Patient Consensus: Patients recommend verifying credentials through the Turkish Medical Association database for specialized treatments. They suggest requesting clinic references directly as these complex oncology cases have limited public discussion.